Susquehanna International Group, LLP Ptc Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $887,388 - $1.1 Million	-29,200 Reduced 35.1%	54,000 $2 Million
Q2 2024 Aug 15, 2024	BUY	$24.69 - $40.12 $1.67 Million - $2.72 Million	67,700 Added 436.77%	83,200 $2.54 Million
Q1 2024 May 07, 2024	SELL	$24.15 - $31.95 $509,564 - $674,145	-21,100 Reduced 57.65%	15,500 $450,000
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $581,854 - $945,714	-32,200 Reduced 46.8%	36,600 $1.01 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $701,433 - $1.31 Million	-31,300 Reduced 31.27%	68,800 $1.54 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $3.48 Million - $5.09 Million	86,100 Added 615.0%	100,100 $4.07 Million
Q1 2023 May 16, 2023	SELL	$38.16 - $48.86 $1.67 Million - $2.14 Million	-43,800 Reduced 75.78%	14,000 $678,000
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $684,012 - $1.12 Million	-20,400 Reduced 26.09%	57,800 $2.21 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $3.27 Million - $4.21 Million	78,200 New	78,200 $3.93 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $806,586 - $1.08 Million	24,200 Added 145.78%	40,800 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $2.2 Million - $2.6 Million	-62,200 Reduced 78.93%	16,600 $661,000
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $954,858 - $1.15 Million	25,800 Added 48.68%	78,800 $2.93 Million
Q2 2021 Aug 11, 2021	SELL	$37.95 - $49.37 $2.52 Million - $3.28 Million	-66,500 Reduced 55.65%	53,000 $2.24 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $3.12 Million - $4.6 Million	66,700 Added 126.33%	119,500 $5.66 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $3.87 Million - $5.45 Million	-80,600 Reduced 60.42%	52,800 $3.22 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $299,706 - $376,662	-6,600 Reduced 4.71%	133,400 $6.24 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $1.23 Million - $1.59 Million	29,000 Added 26.13%	140,000 $7.1 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $5.61 Million - $10.3 Million	-173,300 Reduced 60.96%	111,000 $4.95 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $2.07 Million - $3.22 Million	-64,400 Reduced 18.47%	284,300 $13.7 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $7.75 Million - $11 Million	229,300 Added 192.04%	348,700 $11.8 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $807,576 - $1.03 Million	-22,800 Reduced 16.03%	119,400 $5.37 Million
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $1.55 Million - $2.18 Million	-55,200 Reduced 27.96%	142,200 $5.35 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $363,926 - $567,422	-12,200 Reduced 5.82%	197,400 $6.78 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $793,260 - $1.12 Million	23,400 Added 12.57%	209,600 $9.85 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $639,930 - $1.19 Million	-24,900 Reduced 11.8%	186,200 $6.28 Million
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $991,728 - $1.85 Million	-56,800 Reduced 21.2%	211,100 $5.71 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $4.15 Million - $5.72 Million	-273,900 Reduced 50.55%	267,900 $4.47 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $9.11 Million - $11.7 Million	541,800	541,800 $10.8 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$387 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$334 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$329 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$313 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$307 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account